Robert William Kerwin, M.A. Ph.D. M.B.Chir. - Publications

Affiliations: 
Psychological Medicine Institute of Psychiatry, University of London, London, England, United Kingdom 
Area:
Clinical and translational studies of schizophrenia

193 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Koola MM, Tsapakis EM, Wright P, Smith S, Kerwin Rip RW, Nugent KL, Aitchison KJ. Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites? Journal of Psychopharmacology (Oxford, England). 28: 665-670. PMID 24595968 DOI: 10.1177/0269881114523861  1
2012 Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. Journal of Psychopharmacology (Oxford, England). 26: 408-18. PMID 22303032 DOI: 10.1177/0269881111434624  1
2012 Wolff K, Tsapakis EM, Pariante CM, Kerwin RW, Forsling ML, Aitchison KJ. Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption. Journal of Psychopharmacology (Oxford, England). 26: 419-28. PMID 21969106 DOI: 10.1177/0269881111415737  1
2008 Silberberg G, Levit A, Collier D, St Clair D, Munro J, Kerwin RW, Tondo L, Floris G, Breen G, Navon R. Stargazin involvement with bipolar disorder and response to lithium treatment. Pharmacogenetics and Genomics. 18: 403-12. PMID 18408563 DOI: 10.1097/FPC.0b013e3282f974ca  1
2008 Saiz PA, Susce MT, Clark DA, Kerwin RW, Molero P, Arranz MJ, de Leon J. An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects. Human Psychopharmacology. 23: 107-14. PMID 17972277 DOI: 10.1002/hup.903  1
2008 Compton J, Travis MJ, Norbury R, Erlandsson K, van Amelsvoort T, Daly E, Waddington W, Matthiasson P, Eersels JL, Whitehead M, Kerwin RW, Ell PJ, Murphy DG. Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study. Hormones and Behavior. 53: 61-8. PMID 17956758 DOI: 10.1016/j.yhbeh.2007.08.014  1
2007 Mancama D, Mata I, Kerwin RW, Arranz MJ. Choline acetyltransferase variants and their influence in schizophrenia and olanzapine response. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 849-53. PMID 17503482 DOI: 10.1002/ajmg.b.30468  1
2007 Parsons MJ, Mata I, Beperet M, Iribarren-Iriso F, Arroyo B, Sainz R, Arranz MJ, Kerwin R. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatric Genetics. 17: 159-63. PMID 17417059 DOI: 10.1097/YPG.0b013e328017f8a4  0.8
2007 Clark DA, Mata I, Kerwin RW, Munro J, Arranz MJ. No association between ADRA2A polymorphisms and schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 341-3. PMID 17034020 DOI: 10.1002/ajmg.b.30355  1
2006 Prata DP, Breen G, Munro J, Sinclair M, Osborne S, Li T, Kerwin R, St Clair D, Collier DA. Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes. Psychiatric Genetics. 16: 229-30. PMID 17106420 DOI: 10.1097/01.ypg.0000242190.43773.ce  0.56
2006 Breen G, Prata D, Osborne S, Munro J, Sinclair M, Li T, Staddon S, Dempster D, Sainz R, Arroyo B, Kerwin RW, St Clair D, Collier D. Association of the dysbindin gene with bipolar affective disorder. The American Journal of Psychiatry. 163: 1636-8. PMID 16946192 DOI: 10.1176/appi.ajp.163.9.1636  1
2006 Kanaan RA, Kerwin RW. Lithium and clozapine rechallenge: a retrospective case analysis. The Journal of Clinical Psychiatry. 67: 756-60. PMID 16841625  1
2006 Murphy DG, Daly E, Schmitz N, Toal F, Murphy K, Curran S, Erlandsson K, Eersels J, Kerwin R, Ell P, Travis M. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. The American Journal of Psychiatry. 163: 934-6. PMID 16648340 DOI: 10.1176/appi.ajp.163.5.934  0.36
2006 Clark DA, Mancama D, Kerwin RW, Arranz MJ. Expression of the alpha1A-adrenergic receptor in schizophrenia. Neuroscience Letters. 401: 248-51. PMID 16600500 DOI: 10.1016/j.neulet.2006.03.025  1
2005 Davies SJ, Pandit SA, Feeney A, Stevenson BJ, Kerwin RW, Nutt DJ, Marshall EJ, Boddington S, Lingford-Hughes A. Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence? Alcohol and Alcoholism (Oxford, Oxfordshire). 40: 498-503. PMID 16186142 DOI: 10.1093/alcalc/agh203  1
2005 Clark DA, Arranz MJ, Mata I, Lopéz-Ilundain J, Pérez-Nievas F, Kerwin RW. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population. Biological Psychiatry. 58: 435-9. PMID 16043131 DOI: 10.1016/j.biopsych.2005.04.051  1
2005 Surguladze S, Patel A, Kerwin RW, Knapp M, Travis MJ. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 517-22. PMID 15866352 DOI: 10.1016/j.pnpbp.2005.01.002  1
2005 Bolonna AA, Kerwin RW. Partial agonism and schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 186: 7-10. PMID 15630117 DOI: 10.1192/bjp.186.1.7  1
2005 Staddon S, Arranz MJ, Mancama D, Perez-Nievas F, Arrizabalaga I, Anney R, Buckland P, Elkin A, Osborne S, Munro J, Mata I, Kerwin RW. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population. Schizophrenia Research. 73: 49-54. PMID 15567076 DOI: 10.1016/j.schres.2004.06.011  1
2005 Kerwin R, Osborne S. Pharmacological treatment of schizophrenia Psychiatry. 4: 36-39. DOI: 10.1383/psyt.2005.4.11.36  0.52
2005 Kerwin RW, Bolonna A. Management of clozapine-resistant schizophrenia Advances in Psychiatric Treatment. 11: 101-106. DOI: 10.1192/apt.11.2.101  1
2004 Bolonna AA, Arranz MJ, Mancama D, Kerwin RW. Pharmacogenomics--can genetics help in the care of psychiatric patients? International Review of Psychiatry (Abingdon, England). 16: 311-9. PMID 16194764 DOI: 10.1080/09540260400014369  1
2004 Kerwin RW, Bolonna AA. Is clozapine antisuicidal? Expert Review of Neurotherapeutics. 4: 187-90. PMID 15853559 DOI: 10.1586/14737175.4.2.187  1
2004 Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biological Psychiatry. 56: 406-10. PMID 15364038 DOI: 10.1016/j.biopsych.2004.06.020  1
2004 Munro J, Matthiasson P, Osborne S, Travis M, Purcell S, Cobb AM, Launer M, Beer MD, Kerwin R. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Acta Psychiatrica Scandinavica. 110: 292-8. PMID 15352931 DOI: 10.1111/j.1600-0447.2004.00356.x  0.56
2004 Kerwin R. The National Institute for Clinical Excellence and its relevance to pharmacology Trends in Pharmacological Sciences. 25: 346-348. PMID 15219972 DOI: 10.1016/j.tips.2004.05.010  0.32
2004 Pariante CM, Papadopoulos AS, Poon L, Cleare AJ, Checkley SA, English J, Kerwin RW, Lightman S. Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers. Psychopharmacology. 177: 200-6. PMID 15179544 DOI: 10.1007/s00213-004-1925-4  1
2004 Kerwin RW, Osborne S, Sainz-Fuertes R. Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management. Journal of Psychopharmacology (Oxford, England). 18: 121-3. PMID 15107195 DOI: 10.1177/0269881104040250  1
2004 Flomen R, Knight J, Sham P, Kerwin R, Makoff A. Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene Nucleic Acids Research. 32: 2113-2122. PMID 15087490 DOI: 10.1093/nar/gkh536  0.32
2004 Huezo-Diaz P, Arranz MJ, Munro J, Osborne S, Makoff A, Kerwin RW, Austin J, O'Donovan M. An association study of the neurotensin receptor gene with schizophrenia and clozapine response. Schizophrenia Research. 66: 193-5. PMID 15061255 DOI: 10.1016/S0920-9964(03)00128-2  1
2004 Mata I, Arranz MJ, Patiño A, Lai T, Beperet M, Sierrasesumaga L, Clark D, Perez-Nievas F, Richards L, Ortuño F, Sham P, Kerwin RW. Serotonergic polymorphisms and psychotic disorders in populations from North Spain. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 126: 88-94. PMID 15048655 DOI: 10.1002/ajmg.b.20150  1
2004 Pariante CM, Thomas SA, Lovestone S, Makoff A, Kerwin RW. Do antidepressants regulate how cortisol affects the brain? Psychoneuroendocrinology. 29: 423-47. PMID 14749091 DOI: 10.1016/j.psyneuen.2003.10.009  1
2003 Mancama D, Arranz MJ, Kerwin RW. Pharmacogenomics of psychiatric drug treatment. Current Opinion in Molecular Therapeutics. 5: 642-9. PMID 14755891  1
2003 Kerwin RW. A perspective on progress in pharmacogenomics. American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice. 3: 371-3. PMID 14672517 DOI: 10.2165/00129785-200303060-00003  1
2003 Arranz MJ, Kerwin RW. Advances in the pharmacogenetic prediction of antipsychotic response. Toxicology. 192: 33-5. PMID 14511901 DOI: 10.1016/S0300-483X(03)00248-8  1
2003 Stephenson CM, Suckling J, Dirckx SG, Ooi C, McKenna PJ, Bisbrown-Chippendale R, Kerwin RW, Pickard JD, Bullmore ET. GABAergic inhibitory mechanisms for repetition-adaptivity in large-scale brain systems. Neuroimage. 19: 1578-88. PMID 12948713 DOI: 10.1016/S1053-8119(03)00257-X  1
2003 Pariante CM, Kim RB, Makoff A, Kerwin RW. Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. British Journal of Pharmacology. 139: 1111-8. PMID 12871829 DOI: 10.1038/sj.bjp.0705357  1
2003 Pariante CM, Hye A, Williamson R, Makoff A, Lovestone S, Kerwin RW. The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1553-61. PMID 12784111 DOI: 10.1038/sj.npp.1300195  1
2003 Mancama D, Arranz MJ, Landau S, Kerwin R. Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 119: 2-6. PMID 12707929 DOI: 10.1002/ajmg.b.20020  0.8
2003 Mancama D, Kerwin RW. Role of pharmacogenomics in individualising treatment with SSRIs. Cns Drugs. 17: 143-51. PMID 12617694 DOI: 10.2165/00023210-200317030-00001  1
2003 Mundo E, Tharmalingham S, Neves-Pereira M, Dalton EJ, Macciardi F, Parikh SV, Bolonna A, Kerwin RW, Arranz MJ, Makoff AJ, Kennedy JL. Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Molecular Psychiatry. 8: 241-5. PMID 12610658 DOI: 10.1038/sj.mp.4001218  1
2003 Mancama D, Arranz MJ, Kerwin RW. Genetic perspectives of histamine and muscarinic receptors in schizophrenia and clozapine response Drug Development Research. 60: 119-126. DOI: 10.1002/ddr.10291  1
2003 Arranz MJ, Kerwin RW. Pharmacogenetic and pharmacogenomic research for the prediction of response to antipsychotics in schizophrenia Drug Development Research. 60: 104-110. DOI: 10.1002/ddr.10289  1
2002 Mancama D, Arranz MJ, Munro J, Osborne S, Makoff A, Collier D, Kerwin R. Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neuroscience Letters. 333: 207-11. PMID 12429384 DOI: 10.1016/S0304-3940(02)00178-7  0.8
2002 Arias B, Arranz MJ, Gasto C, Catalan R, Pintor L, Gutierrez B, Kerwin RW, Fananas L. Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT(1A) receptor gene as putative risk factors in major depression. Molecular Psychiatry. 7: 930-2. PMID 12399944 DOI: 10.1038/sj.mp.4001146  1
2002 Shaikh S, Kerwin RW. Receptor pharmacogenetics: relevance to CNS syndromes. British Journal of Clinical Pharmacology. 54: 344-8. PMID 12392580 DOI: 10.1046/j.1365-2125.2002.01679.x  1
2002 Kuperberg G, Kerwin R, Murray R. Developments in the pharmacological treatment of schizophrenia Expert Opinion On Investigational Drugs. 11: 1335-1341. PMID 12387698 DOI: 10.1517/13543784.11.10.1335  0.32
2002 Mata-Pastor I, Arranz-Calderón MJ, Beperet-Urmeneta M, Pérez-Nievas F, Sham P, Kerwin R. Influence of serotonergic transmission on response to olanzapine | Influencia de la transmisión serotoninérgica en la respuesta a olanzapina Actas Espanolas De Psiquiatria. 30: 265-271. PMID 12372221  0.52
2002 Gutiérrez B, Arranz MJ, Huezo-Diaz P, Dempster D, Matthiasson P, Travis M, Munro J, Osborne S, Kerwin RW. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophrenia Research. 58: 93-7. PMID 12363396 DOI: 10.1016/S0920-9964(02)00205-0  1
2002 East SZ, Burnet PW, Kerwin RW, Harrison PJ. An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophrenia Research. 57: 15-26. PMID 12165372 DOI: 10.1016/S0920-9964(01)00323-1  1
2002 Munro JC, Russell AJ, Murray RM, Kerwin RW, Jones PB. IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up. Acta Psychiatrica Scandinavica. 106: 139-42. PMID 12121212 DOI: 10.1034/j.1600-0447.2002.02030.x  1
2002 Staddon S, Arranz MJ, Mancama D, Mata I, Kerwin RW. Clinical applications of pharmacogenetics in psychiatry. Psychopharmacology. 162: 18-23. PMID 12107612 DOI: 10.1007/s00213-002-1084-4  1
2002 Pariante CM, Papadopoulos AS, Poon L, Checkley SA, English J, Kerwin RW, Lightman S. A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis. Biological Psychiatry. 51: 922-30. PMID 12022966 DOI: 10.1016/S0006-3223(01)01314-2  1
2002 Mancama D, Arranz MJ, Kerwin RW. Genetic predictors of therapeutic response to clozapine: current status of research. Cns Drugs. 16: 317-24. PMID 11994021  1
2001 Arranz MJ, Collier D, Kerwin RW. Pharmacogenetics for the individualization of psychiatric treatment. American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice. 1: 3-10. PMID 12173312  1
2001 Kerwin RW, Mancama DT, Arranz MJ. Genetic strategies for the personalization of antipsychotic treatment. Expert Review of Molecular Diagnostics. 1: 275-80. PMID 11901832 DOI: 10.1586/14737159.1.3.275  1
2001 Pariante CM, Makoff A, Lovestone S, Feroli S, Heyden A, Miller AH, Kerwin RW. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. British Journal of Pharmacology. 134: 1335-43. PMID 11704655 DOI: 10.1038/sj.bjp.0704368  1
2001 Sodhi MS, Burnet PW, Makoff AJ, Kerwin RW, Harrison PJ. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Molecular Psychiatry. 6: 373-9. PMID 11443520 DOI: 10.1038/sj.mp.4000920  1
2001 Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder Archives of General Psychiatry. 58: 545-553. PMID 11386983  0.4
2001 Arranz MJ, Munro J, Osborne S, Collier D, Kerwin RW. Applications of pharmacogenetics in psychiatry: personalisation of treatment. Expert Opinion On Pharmacotherapy. 2: 537-42. PMID 11336604 DOI: 10.1517/14656566.2.4.537  1
2001 Bolonna AA, Kerwin RW, Munro J, Arranz MJ, Makoff AJ. Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia. Schizophrenia Research. 47: 99-103. PMID 11163549 DOI: 10.1016/S0920-9964(99)00235-2  1
2001 Arranz MJ, Mancama D, Kerwin RW. Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)). International Journal of Molecular Medicine. 7: 27-30. PMID 11115604  1
2001 Kerwin RW. The role of atypical antipsychotic drugs in schizophrenia Psychiatric Bulletin. 25: 281-282. DOI: 10.1192/pb.25.8.281  1
2001 Staddon SL, Mata I, Osborne S, Munro J, Huezo-Diaz P, Arranz MJ, Kerwin RW. An association study of the 5-HT6 267-C/T polymorphism and antipsychotic response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 619.  1
2001 Mancama DT, Preece P, Landau S, Arranz MJ, Kerwin RW. Relative quantification analysis of cortical histamine 1 and muscarinic 1 receptor expression in patients with schizophrenia American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 623.  1
2001 Staddon LS, Mata I Osborne S, Munro J, Huezo-Diaz P, Arranz MJ, Kerwin RW. An association study of the 5-HT6 267-C/T variant and antipsychotic response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 641-642.  1
2001 Staddon SL, Arranz MJ, Mata I, Mathiasson P, Richards L, Arroyo B, Kerwin RW. An association study of a D3 polymorphism and olanzapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 641.  1
2001 Lai T, Arranz MJ, Mata I, Beperet M, Collier D, Matthiasson P, Kerwin RW. Investigation of 5-HT2C polymorphisms and their influence on olanzapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 641.  1
2001 Dempster D, Mancama D, Gutierrez B, Mata I, Beperet M, Arranz MJ, Kerwin RW. An association study of 5-HT5A and 5-HT3B polymorphisms and olanzapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 641.  1
2001 Arranz MJ, Staddon S, Mata I, Beperet M, Munro J, Osborne S, Kerwin RW. Genetic predictors of olanzapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 581.  1
2001 Mundo E, Tharmalingham S, Dalton J, Bolonna A, Arranz MJ, Kerwin RW, Kennedy JL. The N-Methyl-D-Aspartate receptor subunit 1 gene (GRIN1) and rapid cycling course in Bipolar Disorder American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 621.  1
2001 Aitchison KJ, Zhao JH, Munro J, Collier DA, Makoff AJ, Kerwin RW. Investigation of an association between a CYP1A2 5′ flanking SNP (T-3591G) and response to clozapine American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 582.  1
2001 Collier DA, Osborne S, Munro J, Kerwin RW. Pharmacogenetic methods in schizophrenia International Review of Psychiatry. 13: 47-49.  1
2001 Parsons MJ, D'Souza U, Makoff A, Arranz MJ, Kerwin R. Effects of the -1438-A/G serotonin 2A receptor promotor polymorphism on expression American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 584.  0.8
2000 Aitchison KJ, Jann MW, Zhao JH, Sakai T, Zaher H, Wolff K, Collier DA, Kerwin RW, Gonzalez FJ. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice. Journal of Psychopharmacology (Oxford, England). 14: 353-9. PMID 11198052  1
2000 Aitchison KJ, Gonzalez FJ, Quattrochi LC, Sapone A, Zhao JH, Zaher H, Elizondo G, Bryant C, Munro J, Collier DA, Makoffa AI, Kerwin RW. Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance. Pharmacogenetics. 10: 695-704. PMID 11186132 DOI: 10.1097/00008571-200011000-00004  1
2000 Bell R, Munro J, Russ C, Powell JF, Bruinvels A, Kerwin RW, Collier DA. Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia. American Journal of Medical Genetics. 96: 736-43. PMID 11121172 DOI: 10.1002/1096-8628(20001204)96:6<736::AID-AJMG8>3.0.CO;2-2  1
2000 Arranz MJ, Munro J, Osborne S, Collier D, Kerwin RW. Difficulties in replication of results. Lancet. 356: 1359-60. PMID 11073057  1
2000 Stephenson CM, Bigliani V, Jones HM, Mulligan RS, Acton PD, Visvikis D, Ell PJ, Kerwin RW, Pilowsky LS. Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study. The British Journal of Psychiatry : the Journal of Mental Science. 177: 408-15. PMID 11059993 DOI: 10.1192/bjp.177.5.408  1
2000 Lingford-Hughes AR, Acton PD, Gacinovic S, Boddington SJ, Costa DC, Pilowsky LS, Ell PJ, Marshall EJ, Kerwin RW. Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: preliminary findings from an 123I-iomazenil single photon emission tomography study. Alcoholism, Clinical and Experimental Research. 24: 1449-55. PMID 11003213  1
2000 Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study. Psychopharmacology. 150: 132-40. PMID 10907666 DOI: 10.1007/s002130000435  1
2000 Birkett JT, Arranz MJ, Munro J, Osbourn S, Kerwin RW, Collier DA. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport. 11: 2017-20. PMID 10884063  1
2000 Arranz MJ, Bolonna AA, Munro J, Curtis CJ, Collier DA, Kerwin RW. The serotonin transporter and clozapine response. Molecular Psychiatry. 5: 124-5. PMID 10822334  1
2000 Arranz MJ, Munro J, Birkett J, Bolonna A, Mancama D, Sodhi M, Lesch KP, Meyer JF, Sham P, Collier DA, Murray RM, Kerwin RW. Pharmacogenetic prediction of clozapine response. Lancet. 355: 1615-6. PMID 10821369  1
2000 Arranz MJ, Kerwin RW. Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment. Annals of Medicine. 32: 128-33. PMID 10766404  1
2000 Bolonna AA, Arranz MJ, Munro J, Osborne S, Petouni M, Martinez M, Kerwin RW. No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response. Neuroscience Letters. 280: 65-8. PMID 10696813 DOI: 10.1016/S0304-3940(99)01000-9  1
2000 Jones HM, Travis MJ, Mulligan R, Visvikis D, Gacinovic S, Ell PJ, Kerwin RW, Pilowsky LS. In vivo serotonin 5-HT(2A) receptor occupancy and quetiapine. The American Journal of Psychiatry. 157: 148. PMID 10618043  1
2000 Nebbia G, Pariante CM, Kerwin RW. The molecular mechanisms by which the proinflammatory cytokine, interleukin-1, influences the glucocorticoid receptor: Relevance for glucocorticoid resistance and major depression Italian Journal of Psychiatry and Behavioural Sciences. 10: 10-16.  1
2000 Arranz MJ, Munro J, Osborne S, Gutierrez B, Huezo P, Dempster D, Hassan BA, Niesler B, Rappold G, Kerwin RW. Novel polymorphisms in 5-HT3A receptor gene not related to schizophrenia and clozapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 538.  1
2000 Huezo P, Arranz MJ, Munro J, Osborne S, Austin J, O'Donovan MC, Kerwin RW. Association studies of two neurotensin receptor gene polymorphisms with schizophrenia and clozapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 539.  1
2000 Arranz MJ, Mancama D, Munro J, Osborne S, Travis M, Matthiasson P, Madoz V, Perez-Nievas F, Mata I, Kerwin RW. Influence of polymorphisms in serotonin receptors on response to atypical antipsychotics American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 466-467.  1
2000 Mundo E, Tharmalingam S, Walker M, Bolonna AA, Kerwin RW, Macciardi F, Kennedy JL. Is the NMDAR1 gene implicated in the pathogenesis of Bipolar Disorder? American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 491.  1
2000 Basile VS, Masellis M, Ozdemir V, Quiterio S, Meltzer HY, Lieberman JA, Mancama D, Arranz MJ, Kerwin RW, Kennedy JL. Novel histamine H1 gene polymorphism and clozapine-induced weight gain American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 538-539.  1
1999 Bigliani V, Mulligan RS, Acton PD, Visvikis D, Ell PJ, Stephenson C, Kerwin RW, Pilowsky LS. In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study. The British Journal of Psychiatry : the Journal of Mental Science. 175: 231-8. PMID 10645324  1
1999 Aitchison KJ, Munro J, Wright P, Smith S, Makoff AJ, Sachse C, Sham PC, Murray RM, Collier DA, Kerwin RW. Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation. British Journal of Clinical Pharmacology. 48: 388-94. PMID 10510151 DOI: 10.1046/j.1365-2125.1999.00006.x  1
1999 Travis MJ, Mulligan O, Mulligan RS, Gacinovic S, Waddington W, Ell PJ, Busatto GF, Kerwin RW, Checkley S, Pilowsky LS, Kumar R. Preliminary investigation of the effect of oestradiol treatment on cortical 5-HT2A receptor binding - A single photon emission tomography (SPET) study using 123I-5-I-R91150 Neuroimage. 9: S672.  1
1998 Travis MJ, Busatto GF, Pilowsky LS, Mulligan R, Acton PD, Gacinovic S, Mertens J, Terrière D, Costa DC, Ell PJ, Kerwin RW. 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150. The British Journal of Psychiatry : the Journal of Mental Science. 173: 236-41. PMID 9926100  1
1998 Arranz MJ, Li T, Munro J, Liu X, Murray R, Collier DA, Kerwin RW. Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response. Pharmacogenetics. 8: 481-4. PMID 9918131  1
1998 Lingford-Hughes AR, Acton PD, Gacinovic S, Suckling J, Busatto GF, Boddington SJ, Bullmore E, Woodruff PW, Costa DC, Pilowsky LS, Ell PJ, Marshall EJ, Kerwin RW. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. The British Journal of Psychiatry : the Journal of Mental Science. 173: 116-22. PMID 9850223  1
1998 Arranz MJ, Munro J, Sham P, Kirov G, Murray RM, Collier DA, Kerwin RW. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophrenia Research. 32: 93-9. PMID 9713904 DOI: 10.1016/S0920-9964(98)00032-2  1
1998 Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, Murray R, Sham P, Collier DA. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophrenia Research. 32: 87-92. PMID 9713903 DOI: 10.1016/S0920-9964(98)00024-3  1
1998 Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, Kirov G, Collier DA, Kerwin RW. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Molecular Psychiatry. 3: 61-6. PMID 9491814  1
1998 Ball S, Busatto GF, David AS, Jones SH, Hemsley DR, Pilowsky LS, Costa DC, Ell PJ, Kerwin RW. Cognitive functioning and GABAA/benzodiazepine receptor binding in schizophrenia: a 123I-iomazenil SPET study. Biological Psychiatry. 43: 107-17. PMID 9474443 DOI: 10.1016/S0006-3223(97)00300-4  1
1998 Stefanis NC, Bresnick JN, Kerwin RW, Schofield WN, McAllister G. Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. Brain Research. Molecular Brain Research. 53: 112-9. PMID 9473618 DOI: 10.1016/S0169-328X(97)00285-4  1
1998 Birkett JTP, Ball D, Kerwin RW, Collier DA. No association between two promotor polymorphisms' of the human N-acetyl-transferase gene (AA-NAT) and Alzheimer's disease American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 556.  1
1998 Birkett JTP, Kirov G, Powell J, Murray RM, Kerwin RW, Collier DA. No association between a variable number of tandem repeat (VNTR) in the 3′ untranslated region of the dopamine transporter gene (DAT1) and bipolar affective disorder American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 500-501.  1
1998 Kalkman HO, Charara N, Kuntzelmann G, Munro J, Kerwin RW, Loetseher E. Structural polymorphism in the α2B adrenoceptor: no association with schizophrenia or clozapine responsiveness American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 510.  1
1997 Lucey JV, Costa DC, Busatto G, Pilowsky LS, Marks IM, Ell PJ, Kerwin RW. Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography. Psychiatry Research. 74: 25-33. PMID 10710160 DOI: 10.1016/S0925-4927(96)03017-X  1
1997 Kerwin RW, Aitchison KJ. Cost-effectiveness of clozapine. The British Journal of Psychiatry : the Journal of Mental Science. 171: 584. PMID 9519106  1
1997 Busatto GF, Kerwin RW. Schizophrenia, psychosis, and the basal ganglia. The Psychiatric Clinics of North America. 20: 897-910. PMID 9443356 DOI: 10.1016/S0193-953X(05)70351-8  1
1997 Bell R, Collier DA, Rice SQ, Roberts GW, MacPhee CH, Kerwin RW, Price J, Gloger IS. Systematic screening of the LDL-PLA2 gene for polymorphic variants and case-control analysis in schizophrenia. Biochemical and Biophysical Research Communications. 241: 630-5. PMID 9434759 DOI: 10.1006/bbrc.1997.7741  1
1997 Lucey JV, Burness CE, Costa DC, Gacinovic S, Pilowsky LS, Ell PJ, Marks IM, Kerwin RW. Wisconsin Card Sorting Task (WCST) errors and cerebral blood flow in obsessive-compulsive disorder (OCD). The British Journal of Medical Psychology. 70: 403-11. PMID 9429759  1
1997 Lucey JV, Costa DC, Adshead G, Deahl M, Busatto G, Gacinovic S, Travis M, Pilowsky L, Ell PJ, Marks IM, Kerwin RW. Brain blood flow in anxiety disorders. OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99mTcHMPAO single photon emission tomography (SPET). The British Journal of Psychiatry : the Journal of Mental Science. 171: 346-50. PMID 9373423  1
1997 Mulcrone J, Kerwin RW. The regional pattern of D4 gene expression in human brain. Neuroscience Letters. 234: 147-50. PMID 9364519 DOI: 10.1016/S0304-3940(97)00702-7  1
1997 Travis MJ, Busatto GF, Pilowsky LS, Kerwin RW, Mulligan R, Gacinovic S, Costa DC, Ell PJ, Mertens J, Terriere D. Serotonin: 5-HT2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole. The British Journal of Psychiatry : the Journal of Mental Science. 171: 290-1. PMID 9337994  1
1997 Aitchison KJ, Kerwin RW. Cost-effectiveness of clozapine. A UK clinic-based study. The British Journal of Psychiatry : the Journal of Mental Science. 171: 125-30. PMID 9337946  1
1997 Pilowsky LS, Mulligan RS, Acton PD, Ell PJ, Costa DC, Kerwin RW. Limbic selectivity of clozapine. Lancet. 350: 490-1. PMID 9274589 DOI: 10.1016/S0140-6736(05)63079-6  1
1997 Pilowsky LS, O'Connell P, Davies N, Busatto GF, Costa DC, Murray RM, Ell PJ, Kerwin RW. In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole--a 123I IBZM single photon emission tomography (SPET) study. Psychopharmacology. 130: 152-8. PMID 9106913 DOI: 10.1007/s002130050223  1
1997 Busatto GF, Kerwin RW. Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. Journal of Psychopharmacology (Oxford, England). 11: 3-12. PMID 9097883 DOI: 10.1177/026988119701100102  1
1997 Everall IP, Hudson L, Kerwin RW. Decreased absolute levels of ascorbic acid and unaltered vasoactive intestinal polypeptide receptor binding in the frontal cortex in acquired immunodeficiency syndrome. Neuroscience Letters. 224: 119-22. PMID 9086471 DOI: 10.1016/S0304-3940(97)13473-5  1
1997 Eastwood SL, Kerwin RW, Harrison PJ. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biological Psychiatry. 41: 636-43. PMID 9066986 DOI: 10.1016/S0006-3223(96)00220-X  1
1997 Busatto GF, Pilowsky LS, Costa DC, Mertens J, Terriere D, Ell PJ, Mulligan R, Travis MJ, Leysen JE, Lui D, Gacinovic S, Waddington W, Lingford-Hughes A, Kerwin RW. Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects. European Journal of Nuclear Medicine. 24: 119-24. PMID 9021107 DOI: 10.1007/BF02439542  1
1997 Busatto GF, Pilowsky LS, Costa DC, Ell PJ, David AS, Lucey JV, Kerwin RW. Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. The American Journal of Psychiatry. 154: 56-63. PMID 8988959  1
1997 Busatto GF, Kerwin RW. Reply to commentaries Journal of Psychopharmacology. 11: 28. DOI: 10.1177/026988119701100109  1
1996 Mulcrone J, Kerwin RW. No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenics. Neuroscience Letters. 219: 163-6. PMID 8971805 DOI: 10.1016/S0304-3940(96)13191-8  1
1996 Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study. Psychopharmacology. 124: 148-53. PMID 8935810  1
1996 Arranz MJ, Collier DA, Munro J, Sham P, Kirov G, Sodhi M, Roberts G, Price J, Kerwin RW. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neuroscience Letters. 217: 177-8. PMID 8916101 DOI: 10.1016/0304-3940(96)13094-9  1
1996 Kerwin RW, Collier D. The dopamine D4 receptor in schizophrenia: an update. Psychological Medicine. 26: 221-7. PMID 8685278  1
1996 Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, Smith I, Gill M, Kerwin RW. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Human Genetics. 97: 714-9. PMID 8641685 DOI: 10.1007/s004390050125  1
1996 Sodhi MS, Arranz MJ, Kirov G, Ball DM, Aitchison KJ, Abusaad I, Kerwin RW, Collier DA. Association between psychoses and allelic variation in 5-HT2A and 5-HT2C receptor genes British Journal of Clinical Pharmacology. 41: 457P.  1
1996 Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW. Striatal dopamine D2 receptor binding estimated in vivo in olanzapine-treated schizophrenic patients by [123I]-IBZM single photon emission tomography (SPET) British Journal of Clinical Pharmacology. 41: 439P.  1
1996 Kerwin RW, Barnes TRE. An essay on the use of new antipsychotics Psychiatric Bulletin. 20: 23-29.  1
1995 Busatto GF, David AS, Costa DC, Ell PJ, Pilowsky LS, Lucey JV, Kerwin RW. Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography. Psychiatry Research. 61: 255-64. PMID 8748469 DOI: 10.1016/0925-4927(95)02750-R  1
1995 Sodhi MS, Arranz MJ, Curtis D, Ball DM, Sham P, Roberts GW, Price J, Collier DA, Kerwin RW. Association between clozapine response and allelic variation in the 5-HT2C receptor gene. Neuroreport. 7: 169-72. PMID 8742444  1
1995 Lucey JV, Costa DC, Blanes T, Busatto GF, Pilowsky LS, Takei N, Marks IM, Ell PJ, Kerwin RW. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions. The British Journal of Psychiatry : the Journal of Mental Science. 167: 629-34. PMID 8564319  1
1995 Gray NS, Pilowsky LS, Gray JA, Kerwin RW. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophrenia Research. 17: 95-107. PMID 8541255 DOI: 10.1016/0920-9964(95)00034-J  1
1995 Busatto GF, Pilowsky LS, Costa DC, Ell PJ, Lingford-Hughes A, Kerwin RW. In vivo imaging of GABAA receptors using sequential whole-volume iodine-123 iomazenil single-photon emission tomography. European Journal of Nuclear Medicine. 22: 12-6. PMID 7698149 DOI: 10.1007/BF00997242  1
1995 Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Research. Molecular Brain Research. 29: 211-23. PMID 7609609 DOI: 10.1016/0169-328X(94)00247-C  1
1995 Curtis VA, Kerwin RW. A risk-benefit assessment of risperidone in schizophrenia. Drug Safety. 12: 139-45. PMID 7539272 DOI: 10.2165/00002018-199512020-00006  1
1995 Busatto GF, Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Kerwin RW. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study. Psychopharmacology. 117: 55-61. PMID 7536945 DOI: 10.1007/BF02245098  1
1995 Kerwin RW, Pilowsky LS. Traditional receptor theory and its application to neuroreceptor measurements in functional imaging. European Journal of Nuclear Medicine. 22: 699-710. PMID 7498234 DOI: 10.1007/BF01254574  1
1994 Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Murray RM, Kerwin RW. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study. The British Journal of Psychiatry : the Journal of Mental Science. 164: 16-26. PMID 8137105  1
1994 Busatto GF, Costa DC, Ell PJ, Pilowsky LS, David AS, Kerwin RW. Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: a 99mTc-HMPAO single photon emission tomography (SPET) study. Psychological Medicine. 24: 463-72. PMID 8084941  1
1994 Pedro BM, Pilowsky LS, Costa DC, Hemsley DR, Ell PJ, Verhoeff NP, Kerwin RW, Gray NS. Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia. Psychological Medicine. 24: 423-9. PMID 8084937  1
1994 Kerwin RW, Pilowsky L, Munro J, Shaikh S, Gill M, Collier D. Functional neuroimaging and pharmacogenetic studies of clozapine's action at dopamine receptors. The Journal of Clinical Psychiatry. 55: 57-62. PMID 7961575  1
1994 Eastwood SL, Burnet PW, Beckwith J, Kerwin RW, Harrison PJ. AMPA glutamate receptors and their flip and flop mRNAs in human hippocampus. Neuroreport. 5: 1325-8. PMID 7919190  1
1994 Kerwin RW. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research. The British Journal of Psychiatry : the Journal of Mental Science. 164: 141-8. PMID 7513599  1
1993 McLaughlin DP, Cheetham ME, Kerwin RW. Expression of alternatively-spliced glutamate receptors in human hippocampus. European Journal of Pharmacology. 244: 89-92. PMID 8420792 DOI: 10.1016/0922-4106(93)90062-E  1
1993 Pilowsky LS, Kerwin RW, Murray RM. Schizophrenia: a neurodevelopmental perspective. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 9: 83-91. PMID 8397727 DOI: 10.1038/npp.1993.46  1
1993 Shaikh S, Collier D, Kerwin RW, Pilowsky LS, Gill M, Xu WM, Thornton A. Dopamine D4 receptor subtypes and response to clozapine. Lancet. 341: 116. PMID 8093383 DOI: 10.1016/0140-6736(93)92594-J  1
1993 Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW. Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study. Psychological Medicine. 23: 791-7. PMID 7901865  1
1993 Kerwin RW. Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis. Psychological Medicine. 23: 547-51. PMID 7901861  1
1993 Busatto GF, Pilowsky LS, Ell PJ, Costa DC, Verhoeff NP, Kerwin RW. Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone. The British Journal of Psychiatry : the Journal of Mental Science. 163: 833-4. PMID 7508329  1
1992 Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW. Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet. 340: 199-202. PMID 1353135 DOI: 10.1016/0140-6736(92)90467-H  1
1992 Kerwin RW, Murray RM. A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia. Schizophrenia Research. 7: 1-12. PMID 1350459 DOI: 10.1016/0920-9964(92)90067-F  1
1992 Kerwin RW, Pilowsky LS, Revely A, Everall IP, Bearn J, Launer M. Clozapine. The British Journal of Psychiatry : the Journal of Mental Science. 161: 862-3. PMID 1301045  1
1991 Harrison PJ, McLaughlin D, Kerwin RW. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet. 337: 450-2. PMID 1671470 DOI: 10.1016/0140-6736(91)93392-M  1
1990 Jones PB, Kerwin RW. Left temporal lobe damage in Asperger's syndrome. The British Journal of Psychiatry : the Journal of Mental Science. 156: 570-2. PMID 2386870  1
1990 Kerwin RW, Beats BC. Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiography. Neuroscience Letters. 118: 164-8. PMID 2274265 DOI: 10.1016/0304-3940(90)90617-I  1
1990 Kerwin RW. Monoamine oxidase inhibitors: 30 years of progress? International Review of Psychiatry. 2: 179-185. DOI: 10.3109/09540269009028281  1
1989 Kerwin RW, Nimgaonkar VL. Current biological research in schizophrenia. Reviews in the Neurosciences. 2: 123-36. PMID 21561252 DOI: 10.1515/REVNEURO.1989.2.2.123  1
1989 Kerwin RW. How do the neuropathological changes of schizophrenia relate to pre-existing neurotransmitter and aetiological hypotheses? Psychological Medicine. 19: 563-7. PMID 2572024  1
1988 Kerwin RW. Pathology, phenomenology, and the dopamine hypothesis of schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 152: 141-2. PMID 3167325  1
1988 Kerwin RW, Patel S, Meldrum BS, Czudek C, Reynolds GP. Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet. 1: 583-4. PMID 2894510 DOI: 10.1016/S0140-6736(88)91371-2  1
1988 Murray RM, Kerwin RW. Neurodevelopmental Model of Schizophrenia Archives of General Psychiatry. 45: 1052-1053. DOI: 10.1001/archpsyc.1988.01800350086015  1
1987 Meldrum BS, Kerwin RW. Glutamate receptors and schizophrenia. Journal of Psychopharmacology (Oxford, England). 1: 217-21. PMID 22159133 DOI: 10.1177/026988118700100401  1
1984 Kerwin RW, Rupniak NM, Jenner P, Marsden CD. A comparison of the effects of acute and one year's continuous neuroleptic treatment on the release of [3H]glutamate and [3H]acetylcholine from rat striatal slices. Neuroscience. 11: 205-10. PMID 6143281 DOI: 10.1016/0306-4522(84)90224-0  1
1983 Kerwin RW, Meldrum BS. Effect on cerebral D-[3H]aspartate release of 3-mercaptopropionic acid and methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate. European Journal of Pharmacology. 89: 265-9. PMID 6873162 DOI: 10.1016/0014-2999(83)90503-4  1
1982 O'Shaughessy CT, Bhoola KD, Kerwin RW. A study of possible postsynaptic interactions between peptide neurotransmitters and dopamine in the rat brain Regulatory Peptides. 3: 79.  1
1981 Kerwin RW, Taberner PV. The mechanism of action of sodium valproate. General Pharmacology. 12: 71-5. PMID 6781980 DOI: 10.1016/0306-3623(81)90101-4  1
1981 Pycock CJ, Kerwin RW. The status of glycine as a supraspinal neurotransmitter. Life Sciences. 28: 2679-86. PMID 6115295 DOI: 10.1016/0024-3205(81)90168-5  1
1981 Pycock CJ, Dawbarn D, Kerwin RW. Roles of GABA and glycine in the substantia nigra. Advances in Biochemical Psychopharmacology. 29: 77-87. PMID 6114627  1
1980 Cox B, Kerwin RW, Lee TF, Pycock CJ. A dopamine-5-hydroxytryptamine link in the hypothalamic pathways which mediate heat loss in the rat. The Journal of Physiology. 303: 9-21. PMID 7431248  1
1980 Pycock CJ, Kerwin RW, Carter CJ. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 286: 74-6. PMID 7393327  1
1980 Cox B, Kerwin RW, Lee TF, Pycock CJ. Evidence in vivo for a 5-hydroxytryptamine link in dopamine-receptor-mediated hypothermia in the rat [proceedings]. British Journal of Pharmacology. 68: 168P-169P. PMID 7357182  1
1980 Kerwin RW, Luscombe GP, Pycock CJ, Sverakova K. Behavioural and biochemical studies in rats with N-methyl-D-aspartic acid and kainic acid [proceedings]. British Journal of Pharmacology. 68: 174P-175P. PMID 6986937  1
1980 Kerwin RW, Olpe HR, Schmutz M. The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity. British Journal of Pharmacology. 71: 545-51. PMID 6781578  1
1980 Cox B, Kerwin RW, Lee TF, Pay S, Pycock CJ. Evidence in vitro for a 5-HT link in dopaminergic neurotransmission in the anterior hypothalamic region of the rat: demonstration of a 5-HT link in dopaminergic thermoregulation? [proceedings]. British Journal of Pharmacology. 68: 162P. PMID 6244028  1
1980 Pycock CJ, Carter CJ, Kerwin RW. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. Journal of Neurochemistry. 34: 91-9. PMID 6161214  1
1980 Kerwin RW, Pay S, Bhoola KD, Pycock CJ. Vasoactive intestinal polypeptide (VIP)-sensitive adenylate cyclase in rat brain: regional distribution and localization on hypothalamic neurons. The Journal of Pharmacy and Pharmacology. 32: 561-6. PMID 6106694  1
1980 Kerwin RW, Pycock CJ. GABA inhibition of glycine release from rat substantia nigra Neuroscience Letters. 19: S269.  1
1980 Albano J, Bhoola KD, Kerwin RW. Regional distribution of rat brain vasoactive intestinal polypeptide sensitive adenylate cyclase: Effect of neurotoxic lesions on hypothalamic enzyme activity British Journal of Pharmacology. 69: 283P-284P.  1
1980 Carter CJ, Kerwin RW, Pycock CJ. Indication of subcortical dopamine receptor sensitivity following destruction of frontal cortical dopamine terminals Journal of Physiology. 51P-52P.  1
1980 Kerwin RW, Olpe HR. The effect of sodium valproate on single unit activity in the rat brain British Journal of Pharmacology. 70.  1
1980 Kerwin RW, Pycock CJ. The action of adenosine on [3H]-neurotransmitter release from rat striatal slices in vitro British Journal of Pharmacology. 70: 136p-137p.  1
1979 Kerwin RW, Carter C, Pycock C. A comparison of l- and d-baclofen on dopamine dependent behaviour in the rat. Neuropharmacology. 18: 655-9. PMID 573872 DOI: 10.1016/0028-3908(79)90031-5  1
1979 Kerwin RW, Pycock CJ. A comparison of the effects of GABA and glycine on the release of [3H]-dopamine from rat striatal slices [proceedings]. British Journal of Pharmacology. 66: 106P. PMID 454901  1
1979 Kerwin RW, Pycock CJ. Specific stimulating effect of glycine on 3H-dopamine efflux from substantia nigra slices of the rat. European Journal of Pharmacology. 54: 93-8. PMID 421746 DOI: 10.1016/0014-2999(79)90411-4  1
1979 Kerwin RW, Pycock CJ. Thyrotrophin releasing hormone stimulates release of [3H]-dopamine from slices of rat nucleus accumbens in vitro. British Journal of Pharmacology. 67: 323-5. PMID 115532  1
1979 Kerwin RW, Pycock CJ. Interactions of putative neurotransmitters in the region of the raphé nuclei of the rat [proceedings]. British Journal of Pharmacology. 66: 477P. PMID 43180  1
1979 Kerwin RW, Pycock CJ. The effect of some putative neurotransmitters on the release of 5-hydroxytryptamine and gamma-aminobutyric acid from slices of the rat midbrain raphe area. Neuroscience. 4: 1359-65. PMID 40162 DOI: 10.1016/0306-4522(79)90163-5  1
1979 Kerwin RW, Pycock CJ. Role of taurine as a possible transmitter in the thermoregulatory pathways of the rat. The Journal of Pharmacy and Pharmacology. 31: 466-70. PMID 38317  1
1979 Pycock CJ, Carter CJ, Kerwin RW. Possible involvement of frontal-cortical catecholamine systems in the regulation of neurotransmitter mechanisms at sub-cortical sites in the rat brain [proceedings]. Biochemical Society Transactions. 7: 140-3. PMID 35418  1
Show low-probability matches.